RAPS Webcast: FDA Forecast 2024: What's Next for the FDA in 2024 (On Demand)
What will the FDA do in 2024? In this timely, lively and informative event, regulatory experts from POLITICO's AgencyIQ will explain what regulatory professionals should anticipate in the year ahead based on emerging trends, known issues, regulations and guidance documents and more.
Attendees of this session will come away with a better understanding of what the FDA is working on, why they're working on it, and the potential impact that future actions may have on their business. All regulatory topics discussed during this event will be about or directly related to the pharmaceutical, biopharmaceutical, biotechnology, medical device, diagnostic and dietary supplement sectors.
Registration Fees & Deadlines
Member: $0 | Nonmember: $25
Learning Objectives
- To help regulatory professionals to anticipate actions that FDA is likely to take in 2024
- To understand the challenges that FDA and industry are facing from a regulatory perspective
- To assist regulatory professionals with improving their regulatory strategies for 2024
Who Should Attend?
Regulatory intelligence and policy professionals; Regulatory strategy professionals; Regulatory professionals interested in being proactive in anticipating regulatory actions.
Audience Learning Level:
Intermediate
Speakers:
Alexander J.Gaffney
Executive Director, Regulatory Policy and Intelligence, AgencyIQ
Laura DiAngelo
Director, Research, AgencyIQ
Rachel Coe
Senior Manager, Research, AgencyIQ
Proof of Attendance
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Questions
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected]